Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Abbott Q1 sales

This article was originally published in The Tan Sheet

Executive Summary

Abbott Park, Ill.-based firm's Ross Products division's Q1 sales rose 3.8% to $604 mil., despite absence of revenue from Clear eyes eye drops, Murine eye and ear care products, which were divested to Prestige Brands International last quarter (1"The Tan Sheet" Jan. 20, 2003, In Brief). Sales increase likely was due to Ross' introduction of infant formulas fortified with docosahexaenoic acid and arachidonic acid...

Related Content

Abbott OTCs divested





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts